Kamada (KMDA) Share-based Compensation (IS) (2019 - 2026)
Kamada's Share-based Compensation (IS) was $720,000 in the quarter ended Jun 30, 2026, up 657.9% from $95,000 a year earlier but down 10.0% from the prior quarter.
Powered by 
Analysis
Kamada (KMDA) Share-based Compensation (IS) (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Kamada's Share-based Compensation (IS) was $2.07 million through Jun 30, 2026, up 155.9% year-over-year; for the year ended Dec 31, 2025, it was $845,000, down 2.5% from the prior year.
- Share-based Compensation (IS) shows a five-year compound annual growth rate of -2.9% (years ended Dec 2020 to Dec 2025).
- In earlier years, Share-based Compensation (IS) was $867,000 in the year ended Dec 31, 2024 (-34.0%), $1.31 million in the year ended Dec 31, 2023 (+14.0%), $1.15 million in the year ended Dec 31, 2022 (+118.0%) and $529,000 in the year ended Dec 31, 2021 (-45.9%).
- Quarterly Share-based Compensation (IS) has moved between $25,000 (the quarter ended Dec 31, 2021) and $800,000 (the quarter ended Mar 31, 2026) over five years.
- Compared with a year earlier, Share-based Compensation (IS) has increased for three straight quarters, with growth averaging 283.5% over the last four quarters.
- The best year-over-year quarter for Share-based Compensation (IS) over five years was the quarter ended Dec 31, 2022 (growth of 772.0%); the worst was the quarter ended Dec 31, 2021 (a decline of 79.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Kamada | 497.25 Mn | 206.31 Mn | 22.47 Mn | 720,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 720,000.00 |
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Dec 31, 2023 | 373,000.00 |
| Dec 31, 2022 | 218,000.00 |
| Mar 31, 2022 | 155,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Mar 31, 2021 | 215,000.00 |
| Dec 31, 2020 | 124,000.00 |
| Sep 30, 2020 | 265,000.00 |
| Jun 30, 2020 | 330,000.00 |
| Dec 31, 2019 | 176,000.00 |
| Sep 30, 2019 | 353,000.00 |
| Jun 30, 2019 | 319,000.00 |
API Access
Kamada Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=KMDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();